Page 22 - JCBP-2-3

Journal of Clinical and
Basic Psychosomatics The antidepressant effect of ketamine

Conflict of interest blind, midazolam-controlled PET-MRI clinical trial. J Affect
Disord. 2023;335:105-110.
The authors declare that they have no competing interests.
doi: 10.1016/j.jad.2023.05.024
Author contributions 8. Zhuo C, Ji F, Tian H, et al. Transient effects of multi-infusion

Conceptualization: All authors ketamine augmentation on treatment-resistant depressive
Writing – original draft: Yingying Yin symptoms in patients with treatment-resistant bipolar
depression - An open-label three-week pilot study. Brain
Writing – review & editing: Yonggui Yuan
Behav. 2020;10(8):e01674.
Ethics approval and consent to participate doi: 10.1002/brb3.1674

Not applicable. 9. Sydnor VJ, Lyall AE, Cetin-Karayumak S, et al. Studying pre-
treatment and ketamine-induced changes in white matter
Consent for publication microstructure in the context of ketamine’s antidepressant
effects. Transl Psychiatry. 2020;10(1):432.
Not applicable.
doi: 10.1038/s41398-020-01122-8
Availability of data 10. Vasavada MM, Leaver AM, Espinoza RT, et al. Structural
Not applicable. connectivity and response to ketamine therapy in
major depression: A preliminary study. J Affect Disord.
References 2016;190:836-841.
doi: 10.1016/j.jad.2015.11.018
1. Berman RM, Cappiello A, Anand A, et al. Antidepressant
effects of ketamine in depressed patients. Biol Psychiatry. 11. Carlson PJ, Diazgranados N, Nugent AC, et al. Neural
2000;47(4):351-354. correlates of rapid antidepressant response to ketamine in
treatment-resistant unipolar depression: A preliminary
doi: 10.1016/s0006-3223(99)00230-9
positron emission tomography study. Biol Psychiatry.
2. Wan LB, Levitch CF, Perez AM, et al. Ketamine safety 2013;73(12):1213-1221.
and tolerability in clinical trials for treatment-resistant
depression. J Clin Psychiatry. 2015;76(3):247-252. doi: 10.1016/j.biopsych.2013.02.008
12. Nugent AC, Diazgranados N, Carlson PJ, et al. Neural
doi: 10.4088/JCP.13m08852
correlates of rapid antidepressant response to ketamine in
3. Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer- bipolar disorder. Bipolar Disord. 2014;16(2):119-128.
term antidepressant effects of repeated ketamine infusions
in treatment-resistant major depression. Biol Psychiatry. doi: 10.1111/bdi.12118
2013;74(4):250-256. 13. Li CT, Chen MH, Lin WC, et al. The effects of low-
dose ketamine on the prefrontal cortex and amygdala in
doi: 10.1016/j.biopsych.2012.06.022
treatment-resistant depression: A randomized controlled
4. Wilkinson ST, Ballard ED, Bloch MH, et al. The effect of a study. Hum Brain Mapp. 2016;37(3):1080-1090.
single dose of intravenous ketamine on suicidal ideation: doi: 10.1002/hbm.23085
A systematic review and individual participant data meta-
analysis. Am J Psychiatry. 2018;175(2):150-158. 14. Chen MH, Li CT, Lin WC, et al. Persistent antidepressant
effect of low-dose ketamine and activation in the
doi: 10.1176/appi.ajp.2017.17040472
supplementary motor area and anterior cingulate cortex in
5. Zhou YL, Wu FC, Wang CY, et al. Relationship between treatment-resistant depression: A randomized control study.
hippocampal volume and inflammatory markers following J Affect Disord. 2018;225:709-714.
six infusions of ketamine in major depressive disorder. doi: 10.1016/j.jad.2017.09.008
J Affect Disord. 2020;276:608-615.
15. Sahib AK, Loureiro JRA, Vasavada MM, et al. Single and
doi: 10.1016/j.jad.2020.06.068
repeated ketamine treatment induces perfusion changes in
6. Abdallah CG, Jackowski A, Salas R, et al. The nucleus sensory and limbic networks in major depressive disorder.
accumbens and ketamine treatment in major depressive Eur Neuropsychopharmacol. 2020;33:89-100.
disorder. Neuropsychopharmacology. 2017;42(8):1739-1746.
doi: 10.1016/j.euroneuro.2020.01.017
doi: 10.1038/npp.2017.49
16. Gartner M, de Rover M, Vaclavu L, Scheidegger M, van
7. Li WC, Chen LF, Su TP, et al. Right dorsolateral prefrontal Osch MJP, Grimm S. Increase in thalamic cerebral blood
cortex volumetric reduction is associated with antidepressant flow is associated with antidepressant effects of ketamine
effect of low-dose ketamine infusion: A randomized, double- in major depressive disorder. World J Biol Psychiatry.

Volume 2 Issue 3 (2024) 9 doi: 10.36922/jcbp.2596